Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
Democrats are laying out their plans to rebuild the health care system in the hopes of eventually regaining control of ...
What's changed now is that there's a view in this administration that everything is political,” said Robert Califf, former FDA commissioner.
A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...
Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.
The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private organizations.
A U.S. district judge said he will vacate a declaration by Kennedy that asserted gender-affirming care for young trans people does not meet medical standards of care.
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT event on Thursday.
Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
Many vaccines confer surprising knock-on, or indirect, health benefits when they have been put into widespread use.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results